Alka E. Varghese
Abstract
Climate change is emerging as a critical variable in the discovery and sustainable production of plant derived pharmaceuticals. Medicinal plants synthesize a vast array of secondary metabolites like alkaloids, flavonoids, terpenoids, phenolics and glycosides that underpin the pharmacological activity of numerous conventional and traditional drugs. These phytochemical profiles are not static; they are shaped dynamically by environmental variables. As anthropogenic climate change alters these abiotic factors at an accelerating pace, it is increasingly evident that the biosynthesis, concentration and diversity of bioactive compounds in medicinal flora are being significantly affected, with direct consequences for drug discovery pipelines, therapeutic efficacy, and pharmaceutical supply chains. Rising atmospheric CO2 levels have been shown to alter carbon-to-nitrogen ratios within plant tissues, often favoring carbon-based secondary metabolites such as phenolics and tannins while reducing nitrogen-based compounds like alkaloids. Elevated temperatures can accelerate enzymatic activity and secondary metabolite turnover, sometimes enhancing yields of certain terpenoids and essential oils, but frequently at the cost of compound stability, chemical consistency, and overall plant vigor under heat stress. Altered precipitation patterns and increasing frequency of drought events induce oxidative stress responses in plants, which can upregulate protective phytochemicals such as flavonoids and phenolic acids, yet simultaneously compromise plant survival, growth rate, and geographic range. Shifts in UV-B radiation further modulate the biosynthesis of photoprotective compounds, many of which possess antioxidant and anti-inflammatory properties relevant to human therapeutics. These environmentally driven fluctuations in phytochemical composition pose substantial challenges for drug development, especially with the standardization and clinical efficacy. Species with narrow ecological tolerances face range contraction, habitat loss, or extinction risk, threatening the genetic and chemical diversity that underlies future drug discovery, particularly for rare or endemic medicinal plants historically used in ethnopharmacology. Thus, the paper explores the complex, bidirectional relationship between climate change and plant phytochemistry, with particular attention to the environmental stressors that mediate the accumulation, composition, and physiological functions of bioactive plant metabolites